(Q45303522)

11 December 2017

Longitudinal study of seroprevalence and serostability of 34 human papillomavirus types in European organ transplant recipients (English)

1 reference

11 December 2017

0 references

1

1 reference

11 December 2017

Rachel E Neale

18

0 references

Damiano Abeni

Damiano Abeni

4

0 references

Michael Pawlita

Michael Pawlita

17

0 references

Luigi Naldi

Luigi Naldi

10

0 references

Catherine Harwood

Catherine A Harwood

9

0 references

Tim Waterboer

2

Tim Waterboer

1 reference

11 December 2017

7

Mariet C W Feltkamp

1 reference

11 December 2017

13

Charlotte M Proby

1 reference

11 December 2017

11

Ingo Nindl

1 reference

11 December 2017

5

Maurits de Koning

1 reference

11 December 2017

6

Sylvie Euvrard

1 reference

11 December 2017

16

Sönke J Weissenborn

1 reference

11 December 2017

19

EPI-HPV-UV-CA group

1 reference

11 December 2017

15

Eggert Stockfleth

1 reference

11 December 2017

Jan N Bouwes Bavinck

3

1 reference

11 December 2017

Adèle C Green

8

1 reference

11 December 2017

Herbert J Pfister

12

1 reference

11 December 2017

Wim G Quint

14

1 reference

11 December 2017

language of work or name

English

0 references

publication date

20 November 2012

1 reference

11 December 2017

1 reference

11 December 2017

436

1 reference

11 December 2017

1

1 reference

11 December 2017

91-99

1 reference

Cancer risk following organ transplantation: a nationwide cohort study in Sweden

11 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Stability over time of serum antibody levels to human papillomavirus type 16.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

UV-B irradiation stimulates the promoter activity of the high-risk, cutaneous human papillomavirus 5 and 8 in primary keratinocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Prevalence and stability of antibodies to 37 human papillomavirus types--a population-based longitudinal study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Cancer risk after renal transplantation in the nordic countries, 1964-1986

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Human papillomavirus infection and skin cancer risk in organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Multicenter study of the association between betapapillomavirus infection and cutaneous squamous cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

A case-control study of cutaneous squamous cell carcinoma among Caucasian organ transplant recipients: the role of antibodies against human papillomavirus and other risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

A prospective pilot study of antibodies against human papillomaviruses and cutaneous squamous cell carcinoma nested in the Oxford component of the European Prospective Investigation into Cancer and Nutrition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

The sero-epidemiology of human papillomavirus among Caucasian transplant recipients in the UK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

The seroprevalence of human papillomavirus by immune status and by ethnicity in London.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Characterization and analysis of human papillomaviruses of skin warts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

E6/E7 expression of human papillomavirus types in cutaneous squamous cell dysplasia and carcinoma in immunosuppressed organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Prevalence and associated factors of betapapillomavirus infections in individuals without cutaneous squamous cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

The serological response to papillomaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Epidemiology of solar keratoses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Clearance of oncogenic human papillomavirus (HPV) infection: effect of smoking (United States).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Cutaneotropic Human β-/γ-Papillomaviruses Are Rarely Shared between Family Members

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Cutaneous human papillomaviruses persist on healthy skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Risk factors for cutaneous human papillomavirus seroreactivity among patients undergoing skin cancer screening in Florida.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

The prevalence of common skin conditions in Australian school students: 1. Common, plane and plantar viral warts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Papillomaviruses in non-melanoma skin cancer: epidemiological aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Genomic characterization of ten novel cutaneous human papillomaviruses from keratotic lesions of immunosuppressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Association of seborrhoeic warts with skin cancer in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Comparative transforming potential of different human papillomaviruses associated with non-melanoma skin cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Seroprevalence of 34 human papillomavirus types in the German general population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

E6/E7 expression of human papillomavirus type 20 (HPV-20) and HPV-27 influences proliferation and differentiation of the skin in UV-irradiated SKH-hr1 transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Molecular concepts of virus infections causing skin cancer in organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Seroepidemiological studies of human papilloma virus (HPV-1) infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

A case-control study of betapapillomavirus infection and cutaneous squamous cell carcinoma in organ transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

The promoter of a novel human papillomavirus (HPV77) associated with skin cancer displays UV responsiveness, which is mediated through a consensus p53 binding sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Opposite regulation of the HPV 20-URR and HPV 27-URR promoters by ultraviolet irradiation and cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Factors associated with the seroprevalence of 26 cutaneous and two genital human papillomavirus types in organ transplant patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Prevalence of human papillomavirus DNA in cutaneous neoplasms from renal allograft recipients supports a possible viral role in tumour promotion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Dynamics of human papillomavirus serology in women followed up for 36 months after pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Cancer incidence before and after kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Antibody responses to 26 skin human papillomavirus types in the Netherlands, Italy and Australia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.10.037

10.1016/J.VIROL.2012.10.037

7 January 2021

Identifiers

DOI

1 reference

11 December 2017

1 reference